The ultimate diagnosis of unexplained dyspnoea on exertion: Stay tuned on invasive cardiopulmonary exercise testing and beyond
M. Guazzi
DOI: https://doi.org/10.1177/2047487317713330
IF: 8.526
2017-06-02
European Journal of Preventive Cardiology
Abstract:Dyspnoea, generally exacerbated by exercise, is a common and disabling perception that may occur in a wide variety of disorders involving the lungs and the heart. Exertional dyspnoea is per se meaningful and bears a high prognostic significance even when it is not sustained by a specific organ system, but is just the result of a psychogenic reaction. Although the symptom is clearly defined and reproducible, in approximately 20% of cases its aetiology, the related substrate and the definitive diagnosis may remain challenging in a subgroup of patients who are categorised under the definition of ‘unexplained dyspnoea’. This has immediate confirmation in the multifactorial and complex origin of symptomatology and related clinical phenotype. Generally, reasons for the complaint of dyspnoea are readily determined by history, physical examination and basic screening tests performed at rest, including electrocardiography (ECG), spirometry, biomarkers and chest radiograph. However, when a cause of dyspnoea is not apparent after initial diagnostic work-up obtained at rest, evaluation under exercise with gas exchange analysis by cardiopulmonary exercise testing (CPET) may offer additional insights enhancing sensitivity and specificity in ascertaining reasons of breathlessness, not only in advanced cases but also in the early subclinical stages. A number of CPET measures and derived variables further help in distinguishing a cardiac, pulmonary or peripheral substrate. While lung diseases can be unmasked in most cases by a thorough analysis of ventilatory mechanics, tidal volume over dead space changes, pressure flow/volume loops and O2 saturation, identification of pulmonary vascular, cardiac or peripheral mediators of exercise intolerance and dyspnoea sensation is more problematic on the simple basis of a reduced oxygen consumption (VO2) and inefficient ventilation, because of poor specificity. This is especially true in the presence of pulmonary arterial hypertension (PAH) of any origin, heart failure with preserved ejection fraction (HFpEF), deconditioning and mitochondrial myopathy. In these subjects measurement of pulmonary haemodynamics, left ventricular (LV) filling pressures, Fick cardiac output, and O2 artero-venous difference is essential for addressing the pathophysiological clues of exercise-induced dyspnoea. Invasive CPET (iCPET), combining pulmonary and systemic haemodynamics along with gas analysis, has been proposed as a key examination for the ultimate diagnosis and precise phenotyping of patients with dyspnoea of uncertain origin. In this issue of the European Journal of Preventive Cardiology, Huang et al. report their experience on iCPET applications in the multidisciplinary process involving a large group of patients who were referred to the Brigham and Women’s Hospital Multidisciplinary Dyspnea/Exercise Intolerance Center, USA after inconclusive previous referrals. The data are attractive and place iCPET as a diagnostic approach for solving a significant rate of cases. In a final population of 530 patients, retrospectively identified, iCPET provided a diagnosis which was quite equally distributed among exercise-induced PAH, HFpEF, dysautonomia, oxidative myopathy and primary hyperventilation. Of note, all of the subjects had already been tested by non-invasive CPET. These observations indisputably add evidence in favour of iCPET in the formulation of a definitive diagnosis with a specific haemodynamic algorithm to follow, but what really demonstrates the novelty of